Browse > Article

The Beneficial Effect of Trolox on Sepsis-Induced Hepatic Drug Metabolizing Dysfunction  

Park, Sang-Won (College of Pharmacy, Sungkyunkwan University)
Lee, Sun-Mee (College of Pharmacy, Sungkyunkwan University)
Publication Information
Archives of Pharmacal Research / v.27, no.2, 2004 , pp. 232-238 More about this Journal
Abstract
Trolox is a hydrophilic analogue of vitamin E. The aim of this study was to investigate its effects on hepatic injury, especially alteration in cytochrome P450 (CYP)-dependent drug metabolism during polymicrobial sepsis. Rats were subjected to polymicrobial sepsis by cecal ligation and puncture (CLP). The rats were treated intravenously with Trolox (2.5 mg/kg) or vehicle, immediately after CLP. Serum aminotransferases and lipid peroxidation levels were markedly increased 24 h after CLP. This increase was attenuated by Trolox. Total CYP content and NADPH-P450 reductase activity decreased significantly 24 h after CLP. This decrease in CYP content was attenuated by Trolox. At 24 h after CLP, there was a significant decrease in the activity of these CYP isozymes: CYP1A1, 1A2, 2B1, and 2E1. However, Trolox differentially inhibited the decrease in CYP isozyme activity. Trolox had little effect on the decrease in CYP1A1 activity but Trolox significantly attenuated decreases in CYP1A2 and 2E1 activities. In fact, Trolox restored CYP2B1 activity to the level of activity found in control rats. Our findings suggest that Trolox reduces hepatocellular damage as indicated by abnormalities in hepatic drug-metabolizing function during sepsis. Our data also indicates that this protection is, in part, caused by decreased lipid peroxidation.
Keywords
Trolox; Polymicrobial sepsis; Lipid peroxidation; Cytochrome P450 iszyme activities;
Citations & Related Records

Times Cited By Web Of Science : 5  (Related Records In Web of Science)
Times Cited By SCOPUS : 5
연도 인용수 순위
1 Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haparanta, T., and Mayer, R. T., Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues: a series of sub-strates to distinguish between different induced cytochromes P-450. Biochem. Biopharmacol., 34, 3337-3345 (1985)   DOI   ScienceOn
2 Castle, L. and Perkins, M. J., Inhibition kinetics of chain-breaking phenolic antioxidants in SDS micelles: evidence that intermicellar diffusion rates may be rate-limiting for hydrophobic inhibitors such as alpha-tocopherol. J. Am. Chem. Soc., 108, 6381-6382 (1986)   DOI
3 Nieto, N., Friedman, S. L., and Cederbaum, A. I., Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology, 35, 62-73 (2002)   DOI   ScienceOn
4 Porter, T. D. and Coon, M. J., Cytochrome P-450: multiplicity of isoforms, substrates, and catalytic and regulatory mecha-nisms. J. Biol. Chem., 266, 13469-13472 (1991)   PUBMED
5 Szabo, G., Romics, L. Jr., and Frendl, G., Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis., 6, 1045-1066, (2002)   DOI   ScienceOn
6 Buege, T. A. and Aust S. D., Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310 (1978)   DOI   PUBMED
7 Lee, S.-M. and Cho, T.-S., Effect of Trolox on hypoxia/ reoxygenation-induced injury is isolated perfused rat liver. Arch. Pharm. Res., 20, 471-475 (1997)   DOI   ScienceOn
8 Barkley, L. R. C., Locke, S. J., and Mac-Neil, J. M., Autooxidant in micelles: synergism of vitamin C with lipid-soluble vitamin E and water-soluble Trolox. Can. J. Chem., 63, 366-374 (1985)   DOI
9 Baveja, R., Kresge, N., Ashburn, J. H., Keller, S., Yokoyama,Y, Sonin, N., Zhang, J. X., Huynh, T., and Clemens, M. G., Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock, 18, 415-422 (2002)   DOI   ScienceOn
10 Horton, J. W., Free radical and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy. Toxicology, 189, 75-88 (2003)   DOI   PUBMED   ScienceOn
11 Varda, B., Liat, L., Abraham, N., Yehuda, Z., Margalit, B., and Shlomo, G., The effect of natural antioxidants, NAO and apocynin, on oxidative stress in the rat heart following LPS challenge. Toxicol. Lett., 123, 1-10 (2001)   PUBMED
12 Marubayasch, S., Dohi, K., Ochi, K., and Kawasaki, T., Role of free radicals in ischemic rat liver cell injury. Prevention of damage by $\alpha$-tocopherol administration. Surgery, 99, 184-192 (1986)   PUBMED
13 Dhainaut, J. F., Marin, N., Mignon, A., and Vinsonneau, C., Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit. Care Med., 29 (7 Suppl), S42-S47 (2001)   DOI   ScienceOn
14 Vermillion, J. and Coon, M. J., Purified liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem., 253, 8812-8819 (1978).   PUBMED
15 Wu, T. -W., Hashimoto, N., Au, J. -X, Wu, J., Mickle, D. A., and Carey, D., Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology, 13, 575-580 (1991)   DOI   PUBMED
16 Wu, T. -W., Hashimoto, N., Wu, J., Carey, D., Li, R. -K., Mickle, D., and Wiesel, R. D., The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem. Cell Biol., 68, 1189-1194 (1990)   DOI   ScienceOn
17 Baue, A. E., Multiple organ failure, multiple organ dysfunction, and the systemic inflammatory response syndrome: where do we stand? Shock, 2, 385-397 (1994)   DOI   PUBMED   ScienceOn
18 Hong, J. Y., Pan, J. M., Gonzalez, F. J., Gelboin, H. V., and Yang, C. S., The induction of a specific form of P-450 (P-450j) by fasting. Biochem. Biophys. Res. Commun., 142, 1077-1083 (1987)   DOI   ScienceOn
19 Ring, A. and Stremmel, W., The hepatic microvascular re-sponses to sepsis. Semin. Thromb. Hemost., 26, 589-594 (2000)   DOI   ScienceOn
20 Omura, T. and Sato, R., The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem., 239, 2370-2379 (1964)   PUBMED
21 Adel, A. K., Tarek, K. M., Mohamed, Z. G., and Hanan, M. A., Protective effect of vitamin E, $\beta$-carotene and N-acetylcys-teine from the brain oxidative stress induced in rats by lipopolysaccharide. Int. J. Biochem. Cell Biol., 33, 475-482 (2001)   DOI   ScienceOn
22 Karima, R., Matsumoto, S., Higashi, H., and Matsushima, K., The molecular pathogenesis of endotoxic shock and organ failure. Mol. Med. Today, 5,123-132 (1999)   DOI   ScienceOn
23 Lee, S.-M., Park, M.-J., Cho, T-S., and Clemens, M.-G., Hepatic injury and lipid peroxidation during ischemia and reperfusion. Shock, 13, 279-284 (2000)   DOI   PUBMED   ScienceOn
24 Topfer, F., Lenton, L. M., Bygrave, F. L., and Behm, C. A., Importance of T-cell-dependent inflammatory reactions in the decline of microsomal cytochrome P450 concentration in the livers of rats infected with Fasciola hepatica. Int. J. Parasitol., 25, 1259-1262 (1995)   DOI   ScienceOn
25 Koichi, H., Shinichiro, I., Toshio, H., Toshihiro, M., Tomohisa, F., Tadashi, K., Fumitake, H., and Mitsuhiro, M., Sepsis and cholestasis: basic findings in the sinusoid and bile can-aliculus. J. Hepatobiliary Pancreat. Surg., 8, 20-26 (2001)   DOI   ScienceOn
26 Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., and Ognibene, F. P., Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Int. Med., 113, 227-242 (1990)   DOI   PUBMED   ScienceOn
27 Barriere, S. L. and Lowry, S. F., An overview of mortality risk prediction in sepsis. Crit. Care Med., 23, 376-393 (1995)   DOI   ScienceOn
28 Guengerich, F. P., Dannan, G. A., Wright, S. T, Martin, M. V., and Kaminsky, L. S., Purification and characterization of microsomal cytochrome P-450s. Xenobiotica, 12, 701-716 (1982)   DOI   ScienceOn
29 Schenkman, J. B., Remmer, H., and Estabrook, R. W., Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol., 3, 113-123 (1967)   PUBMED
30 Kokwaro, G. O., Glazier,A. P., Ward, S. A., Breckenridge,A. M., and Edwards, G., Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes. Biochem. Pharmacal., 45, 1235-1241 (1993)   DOI   ScienceOn
31 Parke, D. V. and Sapota, A., Chemical toxicity and reactive oxygen species. Int. J. Occup. Med. Environ. Health, 4, 331-340 (1996)
32 Daly, A. K., Molecular basis of polymorphic drug metabolism. J. Mol. Med., 73, 539-553 (1995)
33 Ingold, K. U., Webb, A. C., Witter, D., Burton, G. W., Metcalfe, T. A., and Muller D. P., Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch. Biochem. Biophys., 259, 224-225 (1987)   DOI   ScienceOn
34 Chaudry, I. H., Wichterman, K. A., and Baue, A. E., Effect of sepsis on tissue on tissue adenine nucleotide levels. Surgery, 85, 205-211 (1979)   PUBMED
35 Goode, H. F., Cowley, H. C., Walker, B. E., Howdle, P. D., and Webster, N. R., Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit. Care Med., 23, 646-651 (1995)   DOI   ScienceOn
36 Doba, T., Burton G. W., and Ingold, K. U., Antioxidant and co-antioxidant activity of vitamin C: the effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochem. Biophys. Act., 835, 298-303 (1985)   DOI   PUBMED   ScienceOn
37 Huet, P. M. and Villenueve, J. P., Determinations of drug disposition in patients with cirrhosis. Hepatology, 3, 913-918 (1983)   DOI   PUBMED